← Eichor
Condition: Stage Iv Ovarian Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Stage Iv Ovarian Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Phase 3 · 59 location(s) · GOG Foundation · NCT05659381Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-
Phase 2 · 2 location(s) · Jiangsu Cancer Institute & Hospital · NCT07311577Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithe
Phase N/A · 1 location(s) · Gynecologic Oncology Group · NCT01000259Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fa
Phase 2 · 3 location(s) · Mayo Clinic · NCT06639074Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression
Phase 2 · 2 location(s) · Tel-Aviv Sourasky Medical Center · NCT06839144Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ C
Phase 3 · 629 location(s) · Children's Oncology Group · NCT03067181Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy
Phase 2 · 1 location(s) · Yonsei University · NCT07340164Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors
NA · 1 location(s) · European Institute of Oncology · NCT06785077Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer
Phase 2 · 1 location(s) · Sunnybrook Health Sciences Centre · NCT05961124Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
Phase 2 · 1 location(s) · University of California, Davis · NCT06268665A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Partic
Phase 2 · 66 location(s) · AbbVie · NCT06890338Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07067255A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · 52 location(s) · AbbVie · NCT06682988Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Can
EARLY_Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT07144826CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors
Phase 1 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT05410717Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
Phase 1 · 2 location(s) · Brigham and Women's Hospital · NCT04701645Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
Phase 1 · 2 location(s) · M.D. Anderson Cancer Center · NCT03968406Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06290193Tumor Microenvironment in Ovarian Cancer
Phase N/A · 1 location(s) · University of Udine · NCT06272240Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer
Phase 2 · 8 location(s) · University Hospital, Linkoeping · NCT05284552A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics
Phase N/A · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05251883Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ov
Phase 1 · 6 location(s) · Hospices Civils de Lyon · NCT04811703Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)
Phase 3 · 1 location(s) · Fudan University · NCT04520074HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
Phase 2 · 28 location(s) · Hansoh BioMedical R&D Company · NCT06014190Single-arm, Prospective Clinical Trial of Efficacy and Safety of Daphnetin Capsules Combined With TC Regimen for Targete
NA · 1 location(s) · The First Hospital of Jilin University · NCT07495397Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
Phase 2 · 1 location(s) · University of Alabama at Birmingham · NCT05952453Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Phase 1/Phase 2 · 1 location(s) · Hadassah Medical Organization · NCT05296564The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
NA · 1 location(s) · New Phase Ltd. · NCT07224464Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3 · 676 location(s) · NRG Oncology · NCT06580314HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy
Phase 2 · 1 location(s) · Instituto Nacional de Cancerologia de Mexico · NCT03275194
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.